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Germcells are theultimate stemcells, and reportsof their in vitroderivationgenerateexcitementdue
to potential applications in reproductive medicine. To date, there is no firm evidence that meiosis,
the hallmark of gametogenesis, can be faithfully replicated outside of the gonad. We propose
benchmarks for evaluating in vitro derivation of germ cells, facilitating realization of their potential.The last decade marked great excitement
and substantial progress in the methods
for in vitro development of germline cells.
These efforts are vital for several reasons.
First, these are the ultimate stem cells.
Second, of all of the cells in the body,
germ cells go through the most dramatic
epigenetic reprogramming, including
specification of imprinted genes. Third,
infertility rates are relatively high histori-
cally (15% of couples in the U.S.), and
societal changes in modern countries
have exacerbated reproductive problems
because both women andmen have been
delaying having children. Fourth, there is a
pressing need to preserve the fertility of
patients undergoing cancer therapy. Fifth,
the lack of robust in vitro systems for
study of meiosis relegates the field to
more difficult and expensive in vivo
studies. Finally, the ability to recapitulate
gametogenesis in vitro would enable
functional evaluation and even correction
of mutant infertility alleles using new
genome editing technologies.
Recently, there have been several
intriguing studies claiming the existence
of female germline stem cells in adults,
differentiation of various stem cells into
germ cells in vivo and in vitro, and recapit-
ulation of meiosis in culture systems. The
aforementioned promise of these studies
for translational medicine applications
has generated excitement among clinical
practitioners and hope for patients
desperate for fertility restoration. How-
ever, because the stakes are high when
it comes to artificial reproductive technol-
ogies involving unprecedented germ cell
manipulation, it is imperative that the sci-entific community applies the highest
standards when conducting and evalu-
ating research concerning in vitro gamete
generation. Indeed, some findings in this
area remain controversial, and even for
publications that are accurate in what
they report, there are serious concerns
about interpretation of the findings.
Here, we lay out rigorous criteria by which
to evaluate claims of recapitulating
meiosis and proper gametogenesis from
putative stem cells of several kinds,
discuss past and future results in the
context of the distinction betweenmeiotic
development and gamete development,
and predict the potential for reproductive
medicine and research if gametogenesis
can indeed be recapitulated accurately.
Gold Standards for Proof of Meiosis
Deriving useful numbers of consistently
competent germ cells from stem cells de-
pends absolutely on the fidelity of
meiosis, which is a defining event of
gametogenesis. Meiosis reduces nuclear
DNA content (‘‘C’’) in sperm to 1C, in ovu-
lated oocytes to 2C, and the nuclear chro-
mosome number (‘‘N’’) of both sperm and
oocytes to 1N (see below and Figure 1).
Meiosis also reshuffles gene alleles by a
form of genetic recombination called
crossing over, which is programmed to
occur at least once between each pair of
homologous chromosomes or chromo-
some arms. Crossovers ensure bipolar
orientation and normal segregation in the
first (reductive) meiotic division. In many
cases, the prolonged meiotic prophase,
characterized by open chromatin, also
serves to provide templates for the tran-Cell 1scription of many genes required for sub-
sequent phases of gametogenesis and/or
early postfertilization development. It is
these hallmarks of meiosis that must be
rigorously established in order for a claim
to be made of successful derivation of
gametes from stem cells. How should
these benchmarks be established and
proven? Below, we outline what we
consider to be key benchmarks—a
checklist—to substantiate successful
in vitro spermatogenesis and oogenesis
(Figure 1).
DNA Content
Flow cytometry (particularly for spermato-
genesis) and/or quantitative cytology
should be employed to verify DNA con-
tent at four critical stages: (1) premeiotic
stage (2C/2N); (2) primary gametocyte
stage (after meiotic S phase, when germ
cells are 4C/2N; note that this is not a
‘‘tetraploid’’ chromosome content as is
often erroneously stated but is simply
the normal post-S phase DNA content of
diploid cells, found also in post-S phase
mitotically proliferating somatic cells); (3)
secondary gametocyte stage (after the
first, reductional, meiotic division when
homologs have separated), when the
cell nuclei are 2C/1N and are formally
haploid; and (4) after the second meiotic
division when individual spermatids are
1C/1N (but unfertilized oocytes never
reach this point unless parthenogeneti-
cally activated).
Themeiotic division process itself is not
suggested as a practical gold standard
because it is rapid, transient, and difficult
to monitor. Nonetheless, it should be kept
in mind that there is substantial evidence57, June 5, 2014 ª2014 Elsevier Inc. 1257
Figure 1. Checklist of Key Events during Mammalian Meiocyte Development
Diagrammed are the processes of spermatocyte and oocyte development and key events in these processes. Of particular importance for assessing accurate
meiocyte development are features denoted by the red checkmarks. Synaptonemal complexes can be visualized by immunolabeling proteins such as SYCP1 or
SYCP3. Markers of recombination include RAD51 (which is bound at hundreds of foci in early meiosis I prophase) and MLH1 (which binds 25 or so foci at sites of
chiasmata in mice). Metaphase figures can be visualized in various ways cytologically (for example, by DAPI staining of DNA and a-tubulin immunolabeling of the
spindle). Mature oocytes should have extruded a single polar body, and fertilized oocytes (zygotes) should have extruded another (occasionally the first polar
body will undergo a division too). A final test is that any zygotes formed from in-vitro-derived gametes should be able to form viable progeny following transfer to
pseudopregnant female hosts.for regulation of both timing (Duncan
et al., 2009) and preferential segregation
(Wu et al., 2005) during the oocyte meiotic
divisions, either of which could influence
developmental outcomes. Moreover,
oocyte-like cells that have not entered
meiosis can produce a polar body with
mitotic segregation of chromatids (Dok-
shin et al., 2013).
In sum, although reductions in DNA
content occur during meiosis, they do
not constitute proof that all events essen-
tial to meiosis have occurred. It is crucial
to emphasize that mammalian oocytes
are normally never 1C because the
maternal genome is reduced to 1C only
after fertilization and the introduction of a
1C male genome. Thus, claims of in-vitro-
derived ‘‘haploid oocytes’’ based on flow
cytometric detection of a 1C population
portray an abnormal biological state not
found in real life and are unacceptable




Either chromosome counts or fluores-
cence in situ hybridization (FISH) analysis1258 Cell 157, June 5, 2014 ª2014 Elsevier In(and preferably both) should be used to
establish chromosome counts in pro-
phase gametocytes and MII metaphase
nuclei (1N chromosome count, 2N chro-
matid count), as well as in the first mitotic
metaphase of embryos produced by in-
vitro-derived gametes (Figure 1). In the
case of in-vitro-derived sperm, FISH ana-
lyses for several chromosomes, including
the X and Y, can verify 1N chromosome
count. For both male and female putative
gametes, it must be demonstrated that
paired homologs, each with two chroma-
tids, are correctly oriented in opposition at
the metaphase I spindle equator.
Recombination
Recombination is essential for the
pairing and proper segregation of homol-
ogous chromosomes during mammalian
meiosis, and it is stimulated by the pro-
grammed induction of double-stranded
breaks (DSBs). Although it is difficult to
obtain definitive evidence for molecular
resolution of DSBs, recombination can
be assessed in spread or whole-mount
chromatin prepared from primary game-
tocytes by using immunolabeling with
antibodies against proteins involved inc.homologous synapsis and recombination
to demonstrate appropriate nuclear and
chromosomal localization (Bolcun-Filas
and Schimenti, 2012; Handel and Schi-
menti, 2010). However, cytological or
molecular detection of these proteins (by
RT-PCR or western analysis, for example)
does not alone constitute evidence that
putative germ cells are executing meiosis
(see below).
Viable Euploid Offspring
The ultimate gold standard for faithful
meiosis is the production of chromoso-
mally normal, healthy offspring. The
robustness of a method for in vitro
gamete derivation should be assessed
by determining the frequency of offspring
produced in relation to the number
of gametes participating in fertilization.
Simply attaining fertilization or a two-cell
embryo is insufficient because gametes
from a number of meiotic mutants can un-
dergo fertilization, but not transition into
viable embryos, and because even
‘‘oocyte-like cells’’ that fail to undergo
meiosis can be fertilized (Dokshin
et al., 2013). Furthermore, embryos with
grossly abnormal chromosome content
can develop significantly beyond the two-
cell stage before arrest.
These ‘‘gold standards’’ constitute the
baseline of what must be demonstrated
to convincingly show that meiosis has
occurred in vitro in a manner that gener-
ates functional gametes. Moreover, in
addition to meiosis, a number of other
parameters are important for fully accu-
rate gametogenesis and subsequent
health of offspring, including epigenetic
reprogramming, a normal transcriptome,
and maintenance of genome stability.
These events are critical for success of
assisted reproductive technologies and,
indeed, remain a challenge for both
cloned animals and iPS cells (Okae
et al., 2013) (Lister et al., 2011). Although
we do not view recapitulation of these
parameters as among the ‘‘gold stan-
dards’’ for demonstrating successful
meiosis in vitro, they are essential for
successful gametogenesis (see com-
ments below).
Reports on the Derivation
of Gametes In Vitro
The generation of gametes in vivo can be
divided roughly into four stages: (1) pri-
mordial germ cell (PGC) specification,
which normally occurs in utero; (2) gonial
maturation; (3) meiosis; and (4) post-
meiotic development, which is limited to
spermiogenesis in males. Among the
most promising reports of ‘‘gametogen-
esis in vitro’’ is the development of
conditions for differentiation of mouse
embryonic stem (ES) or induced pluripo-
tent stem (iPS) cells into primordial
germ-cell-like cells (PGCLCs) that, upon
transplantation into an environment of
appropriate somatic cells in vivo, appear
to undergo meiosis and produce func-
tional sperm and oocytes that contribute
to normal progeny following in vitro fertil-
ization (IVF) (Toyooka et al., 2003; Hayashi
et al., 2011, 2012). These studies have
established that early steps of germ cell
specification (steps 1 and 2) can be suc-
cessfully recapitulated in culture and
have shown that transcription factor re-
programming of iPS or ES cells can be
used for facile derivation of PGCLCs (Na-
kaki et al., 2013). Nevertheless, although
Hayashi et al. documented zygotene-
like ‘‘oocytes’’ derived in culture from
PGCLCs, it has not yet been fully demon-
strated that the definitive and temporalaspects of meiosis occur normally
in vitro (Hayashi et al., 2012). Overall,
this work established that ES or iPS cells
can be converted into PGC-like cells that
appear to be competent for meiosis
in vivo but behave less well than PGCs
following aggregation with embryonic
gonad somatic cells.
Meiosis in vitro remains a significant
challenge, and, indeed, virtually no
studies have fully met the ‘‘gold stan-
dards’’ for faithful meiosis (step 3). For
example, Eguizabal et al. reported
in vitro meiosis from differentiated ES
and iPS cells; the criteria used were DNA
content, epigenetic landscape, and
marker expression, but major hallmarks
of meiosis were not shown, and fertiliza-
tion of putative gametes was not attemp-
ted (Eguizabal et al., 2011). Geijsen et al.
produced embryoid bodies from ES cells,
and from these, PGCLCs were isolated
and differentiated into 1C cells that,
following intracytoplasmic sperm injec-
tion (ICSI), led to blastocysts. However,
hallmarks of meiosis were not shown,
and development beyond the blastocyst
stage was not achieved (Geijsen et al.,
2004), leading to concerns about chromo-
some content of the putative embryos.
Nayernia et al. came very close to
achieving the ‘‘gold standards.’’ They
derived spermatogonial cells lines that
putatively underwent meiosis (however,
the crucial hallmarks of meiosis were not
demonstrated) and differentiated into
cells with 1C DNA content that produced
progeny following ICSI (Nayernia et al.,
2006). In this study, however, the live-
borns were abnormal, and faithful trans-
mission of parental genotypes was not
clear. Collectively, these studies are
promising by showing that PGCLCs can
be derived successfully in vitro from iPS
or ES cells; however, it is still the case
that definitive and successful meiosis
requires the gonadal environment in vivo.
Thus, these systems are quite premature
with respect to clinical applications of
in vitro gametogenesis and also fail to
develop in vitro approaches for basic
research into normal meiosis.
Although findings to date do not pro-
vide an in vitro system meeting the basic
research needs of those interested in
meiosis or spermatogenesis, the suc-
cessful in vitro development of PGCLCs
from iPS cells does open the door forCell 1gene therapy in men with mutations
causing germ cell deficiency. Although
gonadal fate of iPS cells depends on
donor genetic background (Ramathal
et al., 2014), theoretically, patient iPS cells
could be genetically corrected, differenti-
ated into PGCLCs or spermatogonia, and
then transplanted into the patient’s
seminiferous tubules. For females, the re-
quirement for implantation of PGCLC:
embryonic gonad somatic cell aggre-
gates, followed by explantation for IVF,
provides neither a resource for meiosis
research nor a facile solution to infertility.
Indeed, for fertility medicine, the require-
ment for embryonic gonad somatic cells
seems to pose a major practical problem
that is currently insurmountable. More-
over, each culture is a ‘‘one-shot’’ pro-
cess because all of the PGCLCs that
develop into oocytes in the implanted ag-
gregates mature synchronously (with no
formation of a resting pool of primordial
follicles). Nevertheless, this promising
technology lends itself to the iPS gene
therapy paradigm.
Distinctions between Meiotic and
Developmental Programs
Successful gametogenesis requires both
meiosis and acquisition of developmental
competence; as mentioned above,
meiosis alone is not sufficient for develop-
ment of gametes. Recent studies have
demonstrated that ‘‘meiotic’’ and ‘‘devel-
opmental’’ programs of gametogenesis
are separate entities. Meiotic entry in
C. elegans is genetically separable from
the developmental decision to differen-
tiate into sperm or oocytes (Morgan
et al., 2013). Cells that have already
entered meiosis and are genetically
programmed for spermatogenesis can
switch to oogenesis by inhibiting the
Ras/ERK (RAS/MAPK3/1) signaling path-
way. The meiotic and oocyte develop-
ment programs in mice are also formally
separable. Mice that are deficient for the
gene Stra8 (stimulated by retinoic
acid 8), which is required for oocytes to
enter meiosis, are infertile and eventually
undergo complete loss of oocyte-like
cells. However, a recent study found that
a small number of follicles and oocyte-
like cells survived to birth in mutant
females (Dokshin et al., 2013). Even though
these cells failed to undergo any chromo-
somal hallmarks of meiosis (premeiotic57, June 5, 2014 ª2014 Elsevier Inc. 1259
DNA replication, recombination, synapsis,
etc.), they were morphologically indistin-
guishable from oocytes, developed a
zona pellucida, behaved like oocytes by
organizing follicular development, were
ovulated, formed a polar body during
ovulation and in vitro maturation, became
fertilized, and developed into two-cell
embryos. Yet, these cells cannot be identi-
fied as ‘‘oocytes’’ because of failure to
enter meiosis.
How are these findings important with
respect to reports of recapitulation of
oogenesis in vitro or observation of de
novo creation of oocytes in vivo from
stem cells in adults (White et al., 2012)?
Obviously, it is a cautionary tale that
what looks like an oocyte may not be a
true oocyte, and this underscores the
necessity of a checklist applying ‘‘gold
standards’’ for meiosis outlined above.
In particular, there are many cases in the
literature in which ‘‘meiosis-specific’’
markers of recombination and chromo-
some synapsis (such as SYCP3 and
DMC1) have been used as evidence that
an oocyte-like cell is a real oocyte. How-
ever, these markers are not always
restricted to meiotic cells and, when ex-
pressed ectopically, are not actually local-
ized to structures in which they are critical
for meiosis (such as the synaptonemal
complex or recombination repair sites).
Claims for postnatal germline stem
cells in the ovary (Woods et al., 2013)
remain highly controversial (Lei and Spra-
dling, 2013; Yuan et al., 2013; Zhang et al.,
2012; Oatley andHunt, 2012). The distinc-
tions between the meiotic and develop-
mental programs of oogenesis are
relevant here. Reports (White et al.,
2012) that cells from human ovaries can
be isolated and cultured with properties
(germ cell markers; rare mitotic divi-
sion) of ‘‘oogonial stem cells (OSCs)’’
and capable of producing fertilizable
‘‘haploid’’ oocytes when xenotrans-
planted must be evaluated not only by
‘‘gold standard’’ criteria, but also from
the perspective of normal oocyte biology
(where 1C oocytes are not found)
and with respect to separable meiotic
and developmental pathways. Although
putative OSCs may be induced to
undergo the oocyte-like development
pathway, they may not execute the
meiotic pathway. Thus, both challenges
and opportunities arise to understand1260 Cell 157, June 5, 2014 ª2014 Elsevier Inwhat it takes to coordinate the two pro-
cesses. The generation of oocyte-like
cells that are not really oocytes presents
a fascinating opportunity to experimen-
tally unravel the coordinated regulatory
processes required to produce a func-
tional oocyte.
Research and Clinical Applications
for Germline Stem Cells
In spite of the caveats (and in some cases
because of the caveats), developments in
germline stem cell research have enor-
mous potential on several fronts. First,
the benefits for mechanistic understand-
ing of human gametogenesis are great.
Most of our understanding of the genetic
control of gametogenesis, and meiosis in
particular, comes from analysis of normal
and mutant mice. Even though samples
can be obtained, experiments are largely
restricted to the in vivo situation. This is
still tedious, especially for studies of the
early stages of PGC growth and differen-
tiation. With the ability to recapitulate
aspects of gametogenesis in culture, it
becomes feasible to do experiments that
involve cell synchronization, facile addi-
tion, or inhibition of genes and combina-
tions of genes. However, it is important
to consider the fact that there has never
been reliable evidence of mammalian
meiosis in vitro without somatic cells sup-
porting gametogenic processes. Indeed,
there is tight coordination between germ
cells and the surrounding somatic cells
(the follicle cells that surround differenti-
ating oocytes and the Sertoli cells that
surround spermatogenic cells) in vivo,
and it is likely that meiosis and all aspects
of gametogenesis depend on reciprocal
signaling between these two cellular com-
partments (Sugiura et al., 2005; Su et al.,
2008). It is possible that coculture meth-
odologies will be required for accurate
gamete generation in vitro.
The advent of efficient genome editing
technologies is likely to have manifold
benefits for both basic and clinical germ-
line stem cell research. It would immedi-
ately become possible to create null
alleles of any gene in stem cells and then
test the consequence of such mutations
upon gametogenesis. Using homology-
directed repair stimulated by site-specific
induction of double-strand breaks (DSBs)
by CRISPR/Cas9 or TALENs, it becomes
feasible to recapitulate putatively delete-c.rious single-nucleotide polymorphisms
(SNPs) in gametogenesis genes and test
the actual consequence of these SNPs
or de novo mutations in patients who
have undergone genome sequencing to
identify potential causes for infertility.
Identification of germline stem cells, or
their derivation from iPS cells, could
provide impetus to developing new repro-
ductive technologies for species con-
servation or improvement of domestic
animals of economic importance. Even
more ‘‘blue-sky’’ would be the ability to
use patient-specific iPS or germline
stem cells to perform these genome edit-
ing procedures. In the case of men, if
spermatogonia are unaffected, it should
be possible to utilize established culture
methods, coupled with genome editing,
to reconstitute a functional germline. In
females, the iPS route (iPS > PGCLCs >
oogonia) could be taken. However, the
extended manipulations might have un-
acceptable and insurmountable side ef-
fects, as suggested by the low success
rate even without manipulation. If putative
OSCs could be proven to exist and if they
could be harvested and conduct proper
meiosis, manipulation in culture might be
less than in generating iPS cells, but the
rarity of OSCs would preclude screening
them for proper editing. Certainly the iPS
route has the greater potential for clinical
application than OCSs because of more
ready availability, but the challenge
remains to demonstrate the ‘‘gold stan-
dards’’ for meiosis.
The good news is that today there are
multiple routes by which plausible ‘‘repro-
genetic’’ therapies can be envisioned.
However, at least in the near term, the
greatest benefit of the recent advances
in derivation in vitro of germ cells may be
in facilitating our understanding of the
basic biology and mechanistic control of
germ cell development and meiosis.
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